The global faropenem sodium market is predicated to grow at a CAGR of 9.01% during the forecast period. Faropenem is used in the treatment of several bacterial infections of the urinary tract, respiratory tract, skin, ears, nose and gynaecological infections. It obstructs the creation of the bacterial cell wall (a protective covering) that is necessary for their survival. Thereby, kills bacteria. The faropenem sodium market growth is driven by the increase in demand due to rising bacterial infections among population globally. Urinary tract infections (UTIs) are the most common outpatient infections in the US. In 2019, the prevalence of UTIs in women over 65?years of age was approximately 20% compared with approximately 11% in the overall population.
Faropenem is an only penem antibiotics that has around 82.0% efficacy rate against patients with complicated urinary tract infection. Thus, with further increase in such bacterial infections, the demand for faropenem sodium is projected to increase, which will accelerate the market growth. The lack of oversight of off-label use (such as use for clinical indications that differs from those it has been approved for) is the restrain factor that is limiting its wider production.
Impact of COVID-19 Pandemic on Global Faropenem Sodium Market
The COVID-19 pandemic had impacted the global faropenem sodium significantly dueto the lockdown in most of the nations to control the spread of the virus. It affected the overall demand for faropenem sodium in the market.
Segmental Outlook
The global faropenem sodium market research is segmented by Type, and application. Based on type, the market is sub-segmented into purity: 97%-99%, and purity: above99%. On the basis of applications, the market is segmented into injection and tablet.
Global Faropenem Sodium Market Share by Application, 2021 (%)
Global Injection Segment Holds the Prominent Share in the Faropenem Sodium Market
The injection segment held the highest share in the market in 2021. The faropenem sodium injectiions are preferred widely over solid form that is tablets. As raw faropenem sodium is solid powder and in isolating state, the oxidization and hydrolyzation are hard to carry out. Some patients aren’t capable of taking tablet-form medications due to certain conditions, such as vomiting or being unconscious due to which they prefer taking injections of faropenem sodium. Apart from these, the introduction of new products by market players is further projected to drive the segment growth.
Regional Outlooks
The global faropenem sodium market is further segmented based on geography including North America (the US, and Canada), Europe (Italy, Spain, Germany, France, and Others), Asia-Pacific (India, China, Japan, South Korea, and Others), and the Rest of the World (the Middle East & Africa, and Latin America). Among the regions, the Asia Pacific anticipated to hold significant share in the market followed by North America, and then Europe.
Global Faropenem Sodium Market Growth, by Region 2022-2028
The Asia-Pacific Region Expected to Hold Considerable Share in the Global Faropenem Sodium Market
The Asia-Pacific region holds the major share and is anticipated to grow fastest during the forecast period in the faropenem sodium market. The presence of emerging countries such as China, Japan, India, and South Korea are taking big initiatives to the faropenem sodium market. The major players are Kopran Parijat Enterprises, Canagen Pharmaceuticals, BingoChem, Hunan Warrant Chemical are focusing on new product development in order to fulfil the ongoing market growth.
Market Players Outlook
The major companies serving the global faropenem sodium market include Kopran (Parijat Enterprises), Canagen Pharmaceuticals, BingoChem, Hunan Warrant Chemical, Shaoxing Hantai Pharmaceutical, Huanggang LUBAN Pharmaceutical, Shandong Chenlong Pharmaceutical, Rus Biopharm Sun Pharmaceuticals, and others. These market players are focusing on new adoption various marketing strategies such as new product development, merger and acquisition, partnership, collaborations, business expansion and others to stay in competitions and to fulfil market demands.
The Report Covers
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global faropenem sodium Market
• Recovery Scenario of Global faropenem sodium Market
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. BY Region
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Kopran (Parijat Enterprises)
3.1.1.1. Overview
3.1.1.2. Financial Analysis
3.1.1.3. SWOT Analysis
3.1.1.4. Recent Developments
3.1.2. Canagen Pharmaceuticals Inc.
3.1.2.1. Overview
3.1.2.2. Financial Analysis
3.1.2.3. SWOT Analysis
3.1.2.4. Recent Developments
3.1.3. Hangzhou Bingochem Co., Ltd
3.1.3.1. Overview
3.1.3.2. Financial Analysis
3.1.3.3. SWOT Analysis
3.1.3.4. Recent Developments
3.1.4. Hunan Warrant Chemical Pharmaceutical
3.1.4.1. Overview
3.1.4.2. Financial Analysis
3.1.4.3. SWOT Analysis
3.1.4.4. Recent Developments
3.1.5. Shaoxing Hantai Pharmaceutical
3.1.5.1. Overview
3.1.5.2. Financial Analysis
3.1.5.3. SWOT Analysis
3.1.5.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of COVID-19 on Key Players
4. Market Segmentation
4.1. Global Faropenem Sodium Market by Type
4.1.1. Purity: 97%-99%
4.1.2. Purity: Above 99%
4.2. Global Faropenem Sodium Market by Application
4.2.1. Injection
4.2.2. Tablet
5. Regional Analysis
5.1. North America
5.1.1. US
5.1.2. Canada
5.2. Europe
5.2.1. UK
5.2.2. Germany
5.2.3. Italy
5.2.4. Spain
5.2.5. France
5.2.6. Rest of Europe
5.3. Asia-Pacific
5.3.1. China
5.3.2. India
5.3.3. Japan
5.3.4. South Korea
5.3.5. Rest of Asia-Pacific
5.4. Rest of the World
6. Company Profiles
6.1. Alkem Laboratories Ltd.
6.2. DGpeptides Co., Ltd.
6.3. Merck KGaA
6.4. Niksan Healthcare
6.5. Rezcrit Healthcare
6.6. DGpeptides Co., Ltd.
6.7. Glentham Life Sciences Ltd
6.8. Hangzhou Verychem Science and Technology Co., Ltd.
6.9. Hunan Warrant Chiral Pharmaceutical Co., Ltd
6.10. Shandong Chenlong Pharmaceutical Co., Ltd
6.11. RusBiopharm
6.12. Viraj Pharmaceuticals Pvt. Ltd.
6.13. Sun Pharmaceutical Industries Ltd.
6.14. Shop RX Pharmacy
6.15. Trumac Healthcare
1. GLOBAL FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
2. GLOBAL PURITY: 97%-99% FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
3. GLOBAL PURITY: ABOVE 99% FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
4. GLOBAL FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
5. GLOBAL INJECTION FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
6. GLOBAL TABLE FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
7. GLOBAL FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
8. NORTH AMERICAN FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
9. NORTH AMERICAN FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
10. NORTH AMERICAN FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
11. EUROPEAN FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
12. EUROPEAN FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
13. EUROPEAN FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
14. ASIA-PACIFIC FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
15. ASIA-PACIFIC FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
16. ASIA-PACIFIC FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
17. REST OF THE WORLD FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
18. REST OF THE WORLD FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
19. REST OF THE WORLD FAROPENEM SODIUM MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL FAROPENEM SODIUM MARKET, 2021-2028 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL FAROPENEM SODIUM MARKET BY SEGMENT, 2021-2028 ($ MILLION)
3. RECOVERY OF GLOBAL FAROPENEM SODIUM MARKET, 2022-2028 (%)
4. GLOBAL FAROPENEM SODIUM MARKET SHARE BY TYPE, 2021 VS 2028 (%)
5. GLOBAL PURITY: 97%-99% FAROPENEM SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
6. GLOBAL PURITY: ABOVE 99% FAROPENEM SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
7. GLOBAL FAROPENEM SODIUM MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
8. GLOBAL INJECTION FAROPENEM SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
9. GLOBAL TABLE FAROPENEM SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
10. GLOBAL FAROPENEM SODIUM MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
11. US FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
12. CANADA FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
13. UK FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
14. FRANCE FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
15. GERMANY FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
16. ITALY FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
17. SPAIN FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
18. REST OF EUROPE FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
19. INDIA FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
20. CHINA FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
21. JAPAN FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
22. SOUTH KOREA FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
23. REST OF ASIA-PACIFIC FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)
24. REST OF THE WORLD FAROPENEM SODIUM MARKET SIZE, 2021-2028 ($ MILLION)